Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M611370200 on March 12, 2007

J. Biol. Chem., Vol. 282, Issue 19, 14094-14100, May 11, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/19/14094    most recent
M611370200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sastry, K. S. R.
Right arrow Articles by Kulik, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sastry, K. S. R.
Right arrow Articles by Kulik, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Epinephrine Protects Cancer Cells from Apoptosis via Activation of cAMP-dependent Protein Kinase and BAD Phosphorylation*Formula

Konduru S. R. Sastry{ddagger}, Yelena Karpova{ddagger}, Sergey Prokopovich{ddagger}, Adrienne J. Smith{ddagger}, Brian Essau{ddagger}, Avynash Gersappe§1, Jonathan P. Carson§2, Michael J. Weber§, Thomas C. Register, Yong Q. Chen{ddagger}, Raymond B. Penn||, and George Kulik{ddagger}3

From the {ddagger}Department of Cancer Biology, Department of Pathology, Section on Comparative Medicine, and ||Center for Human Genomics, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 and the §Department of Microbiology, University of Virginia, Charlottesville, Virginia 22908

The stress hormone epinephrine is known to elicit multiple systemic effects that include changes in cardiovascular parameters and immune responses. However, information about its direct action on cancer cells is limited. Here we provide evidence that epinephrine reduces sensitivity of cancer cells to apoptosis through interaction with beta2-adrenergic receptors. The antiapoptotic mechanism of epinephrine primarily involves phosphorylation and inactivation of the proapoptotic protein BAD by cAMP-dependent protein kinase. Moreover, BAD phosphorylation was observed at epinephrine concentrations found after acute and chronic psychosocial stress. Antiapoptotic signaling by epinephrine could be one of the mechanisms by which stress promotes tumorigenesis and decreases the efficacy of anti-cancer therapies.


Received for publication, December 12, 2006 , and in revised form, March 5, 2007.

* This work was supported by United States Department of Defense Grant DAMD17-02-1-0154, Grants from the Comprehensive Cancer Center, and Wake Forest University School of Medicine Interim Funding (to G. K.) and National Institutes of Health Grant HL58506 (to R. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S3.

1 Present address: BearingPoint Inc., 8725 W. Higgins Rd. Suites, Chicago, IL 60631.

2 Present address: Center for Molecular Imaging Research, Harvard University, Charlestown, MA 02129.

3 To whom correspondence should be addressed: Dept. of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27157. Tel.: 336-713-7650; Fax: 336-713-7661; E-mail: gkulik{at}wfubmc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. D. Sorensen, P. J. Wild, A. Mortezavi, K. Adolf, N. Torring, S. Heeboll, B. P. Ulhoi, P. Ottosen, T. Sulser, T. Hermanns, et al.
Genetic and Epigenetic SLC18A2 Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy
Clin. Cancer Res., February 15, 2009; 15(4): 1400 - 1410.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement